CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(02): 234-236
DOI: 10.4103/ijmpo.ijmpo_47_17
Practitioner Section

Malignant Peripheral Nerve Sheath Tumor of the Pelvic Retroperitoneum Misdiagnosed as Carcinoma Ovary

Murali Subbaiah
Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India
,
Bhawna A Badhe
Department of Pathology, JIPMER, Puducherry, India
,
Gowri Dorairajan
Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India
,
Priyadarshini Dehuri
Department of Pathology, JIPMER, Puducherry, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

A 52-year-old postmenopausal female was found to have a large solid cystic adnexal mass, compressing the right ureter, and was suspected to have carcinoma ovary. However, it turned out to be a retroperitoneal neurogenic tumor. Malignant peripheral nerve sheath tumors (MPNST) may have cystic areas and may be misdiagnosed as ovarian tumors. Treatment of MPNST involves complete surgical excision of the tumor with a wide margin.



Publication History

Article published online:
23 June 2021

© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 James AW, Shurell E, Singh A, Dry SM, Eilber FC. Malignant peripheral nerve sheath tumor. Surg Oncol Clin N Am 2016; 25: 789-802
  • 2 Gupta G, Mammis A, Maniker A. Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am 2008; 19: 533-43
  • 3 Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant Peripheral Nerve Sheath Tumor: Molecular pathogenesis and current management considerations. J Surg Oncol 2008; 97: 340-9
  • 4 Bradtmöller M, Hartmann C, Zietsch J, Jäschke S, Mautner VF, Kurtz A. et al. Impaired Pten expression in human malignant peripheral nerve sheath tumours. PLoS One 2012; 7: e475954
  • 5 Goertz O, Langer S, Uthoff D, Ring A, Stricker I, Tannapfel A. et al. Diagnosis, treatment and survival of 65 patients with malignant peripheral nerve sheath tumors. Anticancer Res 2014; 34: 777-83
  • 6 Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D. et al. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 2010; 116: 451-8
  • 7 Demehri S, Belzberg A, Blakeley J, Fayad LM. Conventional and functional MR imaging of peripheral nerve sheath tumors: Initial experience. AJNR Am J Neuroradiol 2014; 35: 1615-20
  • 8 Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss's Soft Tissue Tumors. Philadelphia: Saunders/Elsevier 2014; 6: 1155
  • 9 Scheithauer BW, Woodruff JM, Spinner RJ. Peripheral nerve sheath tumors. In: Practical Surgical Neuropathology. Philadelphia: Elsevier 2010; p: 235-85
  • 10 Bernthal NM, Putnam A, Jones KB, Viskochil D, Randall RL. The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma. J Surg Oncol 2014; 110: 813-6